Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1366

1.

Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.

Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M.

J Natl Cancer Inst. 2001 Mar 21;93(6):447-55.

PMID:
11259470
2.

Surgical treatment of early-stage breast cancer in the Department of Defense Healthcare System.

Kelemen JJ 3rd, Poulton T, Swartz MT, Jatoi I.

J Am Coll Surg. 2001 Mar;192(3):293-7.

PMID:
11245370
3.

Improving local control with breast-conserving therapy: a 27-year single-institution experience.

Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F.

Cancer. 2005 Jul 1;104(1):20-9.

4.

Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan.

Horiguchi J, Iino Y, Koibuchi Y, Yokoe T, Takei H, Yamakawa M, Nakajima T, Oyama T, Ando T, Ishida T, Endo K, Takai Y, Suzuki H, Fujii T, Yokomori T, Morishita Y.

Breast Cancer. 2002;9(2):160-5.

PMID:
12016396
5.

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H.

J Natl Cancer Inst. 2000 Jul 19;92(14):1143-50.

PMID:
10904087
6.

Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer.

Parviz M, Cassel JB, Kaplan BJ, Karp SE, Neifeld JP, Penberthy LT, Bear HD.

J Surg Oncol. 2003 Oct;84(2):57-62.

PMID:
14502777
7.

Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.

Kennedy T, Stewart AK, Bilimoria KY, Patel-Parekh L, Sener SF, Winchester DP.

Ann Surg Oncol. 2007 Oct;14(10):2918-27. Epub 2007 Jul 20.

PMID:
17638060
8.

Treatment of breast cancer in countries with limited resources.

Carlson RW, Anderson BO, Chopra R, Eniu AE, Jakesz R, Love RR, Masetti R, Schwartsmann G; Global Summit Treatment Panel.

Breast J. 2003 May-Jun;9 Suppl 2:S67-74.

PMID:
12713499
9.

The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.

Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL.

Cancer. 2005 Nov 15;104(10):2054-62.

10.

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.

Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.

Cancer. 2004 Aug 15;101(4):713-20.

11.

Mortality impact of less-than-standard therapy in older breast cancer patients.

Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA.

J Am Coll Surg. 2008 Jan;206(1):66-75. Epub 2007 Oct 3.

PMID:
18155570
12.

[A population-based study on variations in the use of adjuvant radiotherapy in breast cancer patients].

Nagel G, Röhrig B, Hoyer H, Füller J, Katenkamp D.

Strahlenther Onkol. 2002 Nov;178(11):589-96. German.

PMID:
12426669
13.

Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy.

Newman LA, Kuerer HM, Hunt KK, Singh G, Ames FC, Feig BW, Ross MI, Taylor S, Singletary SE.

Ann Surg Oncol. 1999 Apr-May;6(3):241-8.

PMID:
10340882
14.

Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.

Nesvold IL, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD.

Acta Oncol. 2008;47(5):835-42. doi: 10.1080/02841860801961257.

PMID:
18568481
15.

Local-regional control in breast cancer patients with a possible genetic predisposition.

Freedman LM, Buchholz TA, Thames HD, Strom EA, McNeese MD, Hortobagyi GN, Singletary SE, Heaton KM, Hunt KK.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):951-7.

PMID:
11072150
16.

Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study.

Arndt V, Stegmaier C, Ziegler H, Brenner H.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1311-8. doi: 10.1007/s00432-008-0418-y. Epub 2008 May 27.

PMID:
18504613
17.

[Clinical analysis of resectable breast cancer: a report of 6 263 cases].

Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.

Ai Zheng. 2005 Mar;24(3):327-31. Chinese.

PMID:
15757535
18.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID:
16005576
19.

T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.

Perrucci E, Aristei C, De Angelis V, Anselmo P, Mascioni F, Gori S, Frattegiani A, Latini P.

Tumori. 2004 Jul-Aug;90(4):379-86.

PMID:
15510979
20.

Supplemental Content

Support Center